SC 13G 1 0001.txt SCHEDULE 13G ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No._____) ROSETTA INPHARMATICS, INC. -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $0.001 par value per share -------------------------------------------------------------------------------- (Title of Class of Securities) 777777 10 3 ------------------------------ (CUSIP Number) August 8, 2000 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 777777 10 3 13G Page 2 of 6 ------------------------------------------------------------------------------ NAME OF REPORTING PERSONS. 1. I.R.S. Identification Nos. Of Above Persons AGILENT TECHNOLOGIES, INC., 770518772 ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 2. (a) [_] Not applicable (b) [_] ------------------------------------------------------------------------------ SEC USE ONLY 3. ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4. Delaware ------------------------------------------------------------------------------ SOLE VOTING POWER 5. NUMBER OF 3,459,791 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6. OWNED BY 0 ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7. REPORTING 3,459,791 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8. 0 ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9. 3,459,791 ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 10. Not applicable [_] ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11. 10.9% ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON 12. CO ------------------------------------------------------------------------------ * All calculations are based on 31,769,081 shares of Rosetta Inpharmatics, Inc. Common Stock outstanding according to Rosetta Inpharmatics, Inc.'s Form 10-Q filed with the Securities and Exchange Commission on October 26, 2000. CUSIP No 777777 10 3 13G Page 3 of 6 ITEM 1. (a) NAME OF ISSUER: Rosetta Inpharmatics, Inc. (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 12040 115/t/h Avenue, NE, Suite 210, Kirkland, WA 98034 ITEM 2. (a) NAME OF PERSON FILING: Agilent Technologies, Inc. (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE: 395 Page Mill Road, Palo Alto, California 94306 (c) CITIZENSHIP: Delaware (d) TITLE OF CLASS OF SECURITIES: Common Stock of $0.001 par value per share (e) CUSIP NUMBER: 00846U 10 1 ITEM 3. TYPE OF PERSON REPORTING UNDER RULES 13d-1(b) OR 13d-2(b): Not applicable ITEM 4. OWNERSHIP (a) Amount Beneficially Owned: 3,459,791 (b) Percent of Class: 10.9% (c) Number of Shares as to Which Such Person Has: (i) Sole power to vote or to direct the vote: 3,459,791 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or direct the disposition of: 3,459,791 (iv) Shared power to dispose or direct the disposition of: 0
CUSIP No 777777 10 3 13G Page 4 of 6 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable ITEM 10. CERTIFICATION Not applicable CUSIP No 777777 10 3 13G Page 5 of 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. December 18, 2000 By: /s/ Marie Oh Huber Date ----------------------------------- Marie Oh Huber Vice President, Assistant Secretary and Assistant General Counsel